Clinical Insights and Strategies to Improve NSCLC Care
  • Program Overview
    Clinical Insights and Strategies to Improve NSCLC Care
    Explore key issues in the management of advanced NSCLC in this educational program designed to keep you abreast of rapidly evolving treatment practices. Gain expert insights on new developments as they emerge with CME/CE-certified interactive modules, short expert commentaries, and an Interactive Decision Support Tool that will let you compare your treatment choices for specific patient scenarios in advanced NSCLC with those of 5 experts.
  • Featured content
    Download this simple resource providing an overall summary of advanced NSCLC care including an up-to-date treatment algorithm, toxicity management, and a listing of key enrolling clinical trials.
    Date Posted: 2/15/2018
  • Featured content
    What is the best approach for our patients with progressive ALK-positive NSCLC? Here I share my thoughts based on the latest available evidence on using ALK inhibitors in the setting of progressive disease.
    Date Posted: 1/22/2018
  • Featured content
    What advances coming in 2018 have the most potential to affect the care of our patients with advanced NSCLC? H. Jack West, MD, offers his thoughts.
    Date Posted: 12/28/2017
  • 1
  • 2
  • 3
  • 4

Latest Content

5 of 5 Shown
  • A New Nivolumab Dosing Option for Our Patients With Advanced NSCLC

    Edward B. Garon MD, MS - 4/16/2018
    How will the new dosing schedule for nivolumab in NSCLC affect our current practice? Here are my thoughts.
  • Advanced NSCLC: Expert Insight on the Selection of First-line and Second-line Therapy—2018

    Use this Interactive Decision Support Tool to get treatment recommendations from David R. Gandara, MD; Melissa L. Johnson, MD; Suresh S. Ramalingam, MD; Heather Wakelee, MD; and H. Jack West, MD, for your patients with advanced NSCLC.
    Date Posted: 3/13/2018
  • Advanced NSCLC Management: A Resource for Clinicians

    Download this simple resource providing an overall summary of advanced NSCLC care including an up-to-date treatment algorithm, toxicity management, and a listing of key enrolling clinical trials.
    Date Posted: 2/15/2018
  • My Approach for Managing Patients With Progressive ALK-Positive NSCLC

    Lyudmila Bazhenova MD - 1/22/2018 4 comments / Last Comment: 3/9/2018
    What is the best approach for our patients with progressive ALK-positive NSCLC? Here I share my thoughts based on the latest available evidence on using ALK inhibitors in the setting of progressive disease.
  • Immunotherapy and Targeted Therapy in NSCLC: Where Are We Going in 2018?

    H. Jack West MD - 12/28/2017 5 comments / Last Comment: 2/8/2018
    What advances coming in 2018 have the most potential to affect the care of our patients with advanced NSCLC? H. Jack West, MD, offers his thoughts.
5 of 5 Shown
Show 0 More
Loading...